Mary E. Wright - 28 Jul 2025 Form 3 Insider Report for Inogen Inc (INGN)

Signature
/s/ Mary Wright
Issuer symbol
INGN
Transactions as of
28 Jul 2025
Net transactions value
$0
Form type
3
Filing time
07 Aug 2025, 16:32:10 UTC
Next filing
03 Mar 2026

Key filing fact

Mary E. Wright filed Form 3 for Inogen Inc (INGN) on 07 Aug 2025.

Key facts

  • This page summarizes Mary E. Wright's Form 3 filing for Inogen Inc (INGN).
  • 0 reported transactions and 3 derivative rows are listed below.
  • Filing timestamp: 07 Aug 2025, 16:32.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC Source

Ownership activity is grounded in SEC Form 3 disclosures.

See Original Filing

Reporting Owners (1)

CIK 0002079955 Primary reporting owner

Wright Mary E

Relationship
VP, Chief Accounting Officer
Address
C/O INOGEN, INC., 859 WARD DRIVE, GOLETA
Signature
/s/ Mary Wright
Signature date
07 Aug 2025

Transactions Table

INGN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
12,180
Date
28 Jul 2025
Ownership
Direct
Footnotes
F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

INGN holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
28 Jul 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,755
Exercise price
$0.000000
Footnotes
F2, F3
INGN holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
28 Jul 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,499
Exercise price
$0.000000
Footnotes
F2, F4
INGN holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
28 Jul 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
9,003
Exercise price
$0.000000
Footnotes
F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 60 shares of Inogen Common Stock acquired pursuant to Inogen's Employee Stock Purchase Plan ("ESPP").
F2 Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
F3 Subject to the reporting person's continued service, the restricted stock units shall vest on March 1, 2026.
F4 Subject to the reporting person's continued service, the restricted stock units shall vest on March 1, 2027.
F5 Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest one year from March 1, 2025 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

Remarks:

Exhibit 24 - Power of Attorney.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .